𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: Overt and occult infection

✍ Scribed by Mahmoud Reza Pourkarim; Philippe Lemey; Samad Amini-Bavil-Olyaee; Lieselot Houspie; Jannick Verbeeck; Mustafizur Rahman; Piet Maes; Eric Vanwijngaerden; Frederik Nevens; Marc Van Ranst

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
130 KB
Volume
83
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) have similar transmission routes, implying that patients infected with HIV are at particular risk for HBV infection. Patients who are co‐infected with HIV and HBV progress more rapidly to end‐stage liver disease and different HBV genotypes may have a distinct impact on disease progression. One hundred ninety‐one anti‐HBc‐positive sera from Belgian patients co‐infected with HIV and HBV were collected during 1998–2008. Full‐length HBV genomes as well as large S or partial S genes were amplified and their molecular evolutionary history was analyzed. Clinically, 30 (65.8%) patients were categorized as “overt infection” and 16 (34.7%) cases were categorized as “occult infection.” Five distinct HBV genotypes comprising A (69.6%), E (19.6%), followed by D, C, and G were detected. HBV genotype A was observed in all clinical groups and in patients with varying ethnical background. HBV genotype E could be detected in African patients who were mostly infected by heterosexual contacts. Several clinically important mutations at the HBs major hydrophilic region were detected in the new isolates but with no significant difference between occult and overt infection. The high prevalence of HBV genotype A in overt and occult cases, and in particular the detection of certain HBV subgenotypes in patients co‐infected with HIV and HBV that carry diagnostic escape mutations, may provide useful information for national guidelines for prophylaxis and treatment. J. Med. Virol. 83:1876–1884, 2011. © 2011 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Comparative analysis of hepatitis B viru
Comparative analysis of hepatitis B virus genotype a molecular evolution in patients infected with HBV and in patients co-infected with HBV and HIV
✍ L. Cassino; C. Torres; V. Mbayed; N. Laufer; R.H. Campos; J. Quarleri 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract HIV infection has a significant impact on the natural progression of liver disease caused by infection with hepatitis B virus (HBV), but its role in the molecular evolution of HBV is unknown. It is difficult to study the molecular evolution of HBV longitudinally considering its genomic

Molecular characterization and functiona
Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C
✍ Yong Fang; Xu Teng; Wei-Zhen Xu; Di Li; Hong-Wei Zhao; Li-Juan Fu; Feng-Min Zhan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract Occult HBV infection is defined as the persistence of HBV DNA in individuals negative for HBV surface antigen (HBsAg), and many different mechanisms have been reported in different countries. However, in China, one of the endemic areas for HBV infection, no reports have been published o

Mutations associated with lamivudine-res
Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: Implications for antiretroviral therapy in HBV and HIV co-infected South African patients
✍ S. Gloria Selabe; Azwidowi Lukhwareni; Ernest Song; Yeegan G.M. Leeuw; Rosemary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

## Abstract This was an exploratory study to investigate lamivudine‐resistant hepatitis B virus (HBV) strains in selected lamivudine‐naïve HBV carriers with and without human immunodeficiency virus (HIV) co‐infection in South African patients. Thirty‐five lamivudine‐naïve HBV infected patients with

Occult hepatitis B infection and HBV rep
Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma
✍ Danny Ka Ho Wong; Fung Yu Huang; Ching Lung Lai; Ronnie Tung Ping Poon; Wai Kay 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

We aimed to investigate the incidence of occult hepatitis B infection (OBI) in patients with ''cryptogenic'' hepatocellular carcinoma (HCC) and to study the HBV replicative activity in these patients. Tumorous and adjacent nontumorous liver tissues were obtained from 33 cryptogenic HCC patients and

Prevalence and clinical significance of
Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without Co-infection with hepatitis C virus
✍ Paolo Fabris; Giulia Tositti; Maria Teresa Giordani; Luisa Romanò; Corrado Bette 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## Abstract Although hepatitis C virus (HCV) is a recognized cause of circulating cryoglobulins, the role of human immunodeficiency virus (HIV) in the pathogenesis of cryoglobulinemia has not been investigated extensively. To evaluate the prevalence of circulating cryoglobulins and to assess the re

Occult hepatitis B virus infection in th
Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: Clinically relevant or a diagnostic problem?
✍ M. Rodríguez-Torres; J. Gonzalez-Garcia; N. Bräu; R. Solá; S. Moreno; J. Rockstr 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

## Abstract The clinical relevance of occult hepatitis B virus (HBV) infection, defined as detectable HBV DNA serum/liver, in the absence of hepatitis B surface antigen (HBsAg), is unclear. We determined the prevalence of serum occult HBV infection in HIV/HCV co‐infected patients enrolled in APRICO